Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial
Novo Nordisk A/S
John Deanfield; A Michael Lincoff; Steven E Kahn; Scott S Emerson; Ildiko Lingvay; Benjamin M Scirica; Jorge Plutzky; Robert F Kushner; Helen M Colhoun; G Kees Hovingh; Signe Stensen; Peter E Weeke; Ole Kleist Jeppesen; Rafael Bravo; Chau-Chung Wu; Issei Komuro; Ferruccio Santini; Jøran Hjelmesæth; Miguel Urina-Triana; Silvio Buscemi; Donna H Ryan
Department of Biostatistics, University of Washington, WA, USA.